DWA
VSTM icon

Dorsey Wright & Associates’s Verastem VSTM Stock Holding History

Dorsey Wright & Associates’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,272
Closed -$18.5K – 284
2023
Q3 		$18.5K Buy
+2,272
New +$21.8K 0.01% 268
2018
Q4 		– Sell
-174
Closed -$15K – 354
2018
Q3 		$15K Buy
+174
New +$17.3K ﹤0.01% 223

Other funds holding VSTM

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dorsey Wright & Associates's VSTM Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of Verastem (VSTM) in Q4 2023, closing a stake of 2,272 shares — an estimated $18.5K sold.

Dorsey Wright & Associates first reported a position in VSTM in Q3 2018 and held it in 2 quarters. The position peaked at $18.5K in Q3 2023. 58 funds tracked by Wall St. Rank hold VSTM as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining Verastem position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,272 Verastem shares in Q4 2023, an estimated $18.5K.
  • Dorsey Wright & Associates first reported a position in Verastem in Q3 2018 and held it in 2 quarters.
  • Dorsey Wright & Associates's Verastem position peaked at $18.5K in Q3 2023.
  • 58 funds tracked by Wall St. Rank held Verastem as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.